FEIBA: payments to doctors
Payments that named FEIBA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $200K
- Providers
- 46
- Transactions
- 95
- Average per transaction
- $2,103
The per-transaction average — $2,103 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 46 providers the average total is $4,343, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $187,337 | 93.8% |
| Shire North American Group Inc | $12,462 | 6.2% |